Kits Eyecare Stock Net Income

KTYCF Stock  USD 14.45  0.90  6.64%   
As of the 17th of February 2026, Kits Eyecare secures the Mean Deviation of 2.43, risk adjusted performance of 0.1632, and Downside Deviation of 3.69. Kits Eyecare technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices. Please verify Kits Eyecare information ratio, value at risk, as well as the relationship between the Value At Risk and expected short fall to decide if Kits Eyecare is priced some-what accurately, providing market reflects its recent price of 14.45 per share. Given that Kits Eyecare has jensen alpha of 0.6701, we recommend you to check Kits Eyecare's last-minute market performance to make sure the company can sustain itself at a future point.
Kits Eyecare's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Kits Eyecare's valuation are provided below:
Kits Eyecare does not presently have any fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  
Understanding that Kits Eyecare's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Kits Eyecare represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Kits Eyecare's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.

Kits Eyecare 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Kits Eyecare's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Kits Eyecare.
0.00
11/19/2025
No Change 0.00  0.0 
In 3 months and 1 day
02/17/2026
0.00
If you would invest  0.00  in Kits Eyecare on November 19, 2025 and sell it all today you would earn a total of 0.00 from holding Kits Eyecare or generate 0.0% return on investment in Kits Eyecare over 90 days. Kits Eyecare is related to or competes with ASOS Plc, Marstons PLC, AMA Group, and Kogan. Kits Eyecare Ltd. operates a digital eyecare platform for eyes in the United States and Canada More

Kits Eyecare Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Kits Eyecare's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Kits Eyecare upside and downside potential and time the market with a certain degree of confidence.

Kits Eyecare Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Kits Eyecare's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Kits Eyecare's standard deviation. In reality, there are many statistical measures that can use Kits Eyecare historical prices to predict the future Kits Eyecare's volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Kits Eyecare's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
11.0014.4517.90
Details
Intrinsic
Valuation
LowRealHigh
10.2013.6517.10
Details

Kits Eyecare February 17, 2026 Technical Indicators

Kits Eyecare Backtested Returns

Kits Eyecare appears to be somewhat reliable, given 3 months investment horizon. Kits Eyecare has Sharpe Ratio of 0.21, which conveys that the firm had a 0.21 % return per unit of risk over the last 3 months. By analyzing Kits Eyecare's technical indicators, you can evaluate if the expected return of 0.73% is justified by implied risk. Please exercise Kits Eyecare's Mean Deviation of 2.43, risk adjusted performance of 0.1632, and Downside Deviation of 3.69 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Kits Eyecare holds a performance score of 16. The company secures a Beta (Market Risk) of 0.58, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Kits Eyecare's returns are expected to increase less than the market. However, during the bear market, the loss of holding Kits Eyecare is expected to be smaller as well. Please check Kits Eyecare's expected short fall, and the relationship between the value at risk and rate of daily change , to make a quick decision on whether Kits Eyecare's current price movements will revert.

Auto-correlation

    
  0.03  

Virtually no predictability

Kits Eyecare has virtually no predictability. Overlapping area represents the amount of predictability between Kits Eyecare time series from 19th of November 2025 to 3rd of January 2026 and 3rd of January 2026 to 17th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Kits Eyecare price movement. The serial correlation of 0.03 indicates that only 3.0% of current Kits Eyecare price fluctuation can be explain by its past prices.
Correlation Coefficient0.03
Spearman Rank Test-0.13
Residual Average0.0
Price Variance0.5
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

Based on the recorded statements, Kits Eyecare reported net income of (14.62 Million). This is 102.86% lower than that of the Consumer Cyclical sector and 101.71% lower than that of the Specialty Retail industry. The net income for all United States stocks is 102.56% higher than that of the company.

Kits Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Kits Eyecare's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Kits Eyecare could also be used in its relative valuation, which is a method of valuing Kits Eyecare by comparing valuation metrics of similar companies.
Kits Eyecare is currently under evaluation in net income category among its peers.

Kits Fundamentals

About Kits Eyecare Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Kits Eyecare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kits Eyecare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kits Eyecare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Kits Pink Sheet

Kits Eyecare financial ratios help investors to determine whether Kits Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kits with respect to the benefits of owning Kits Eyecare security.